| 000 | 01831 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250516103023.0 | ||
| 264 | 0 | _c20130103 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1556-5653 | ||
| 024 | 7 |
_a10.1016/j.fertnstert.2012.06.041 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Bennetot, Marianne | |
| 245 | 0 | 0 |
_aFertility after tubal ectopic pregnancy: results of a population-based study. _h[electronic resource] |
| 260 |
_bFertility and sterility _cNov 2012 |
||
| 300 |
_a1271-6.e1-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Video-Audio Media | ||
| 650 | 0 | 4 |
_aAbortifacient Agents, Nonsteroidal _xtherapeutic use |
| 650 | 0 | 4 |
_aAbortion, Spontaneous _xepidemiology |
| 650 | 0 | 4 | _aAbortion, Therapeutic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFertility |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aLaparoscopy |
| 650 | 0 | 4 | _aLive Birth |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy, Ectopic _xepidemiology |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSalpingectomy |
| 650 | 0 | 4 | _aSalpingostomy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTime-to-Pregnancy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRabischong, Benoît | |
| 700 | 1 | _aAublet-Cuvelier, Bruno | |
| 700 | 1 | _aBelard, Fabien | |
| 700 | 1 | _aFernandez, Hervé | |
| 700 | 1 | _aBouyer, Jean | |
| 700 | 1 | _aCanis, Michel | |
| 700 | 1 | _aPouly, Jean-Luc | |
| 773 | 0 |
_tFertility and sterility _gvol. 98 _gno. 5 _gp. 1271-6.e1-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.fertnstert.2012.06.041 _zAvailable from publisher's website |
| 999 |
_c21962769 _d21962769 |
||